As consumers turn to artificial intelligence to research hearing aids, published clinical data will matter more, says Eric Bernard, CEO of the world’s largest hearing aid maker.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is an industry executive's opinion on market trends, not clinical guidance; however, it signals that pressure for published evidence on hearing aids may grow, which could eventually benefit evidence-based practice.
If AI-driven consumer research genuinely rewards published clinical evidence, manufacturers may face stronger market incentives to fund independent trials, raising the overall evidence base for hearing aid technologies.
- 01Sonova CEO Eric Bernard argues AI consumer research tools are raising the bar for clinical evidence in hearing aids.
- 02Bernard's position implies that unpublished or weak evidence may disadvantage products when AI summarises search results for patients.
- 03The argument reflects a broader industry shift where patients increasingly use AI to pre-research hearing health decisions.
- 04This is an executive opinion piece, not a study — no data are provided to support the claim.
AI-driven consumer research is increasing the importance of published clinical evidence for hearing aids.
opinionunclear